May 31, 2017 - By marketbeat
Mead Johnson Nutrition Company is a pediatric nutrition company. The company has market cap of $16.43 billion. The Firm makes, distributes and sells infant formulas, children’s nutrition and other nutritional products. It has a 28.03 P/E ratio. The Firm operates through three divisions: Asia, Latin America and North America/Europe.
Balchem Corporation (BCPC) formed H&S with $72.11 target or 9.00% below today’s $79.24 share price. Balchem Corporation (BCPC) has $2.53 billion valuation. The stock decreased 0.93% or $0.74 during the last trading session, reaching $79.24. About shares traded. Balchem Corporation (NASDAQ:BCPC) has risen 37.77% since May 31, 2016 and is uptrending. It has outperformed by 21.07% the S&P500.
Analysts await Mead Johnson Nutrition CO (NYSE:MJN) to report earnings on July, 27. They expect $0.75 EPS, down 14.77% or $0.13 from last year’s $0.88 per share. MJN’s profit will be $137.91 million for 29.78 P/E if the $0.75 EPS becomes a reality. After $0.80 actual EPS reported by Mead Johnson Nutrition CO for the previous quarter, Wall Street now forecasts -6.25% negative EPS growth.
Vgi Partners Pty Ltd holds 7.12% of its portfolio in Mead Johnson Nutrition CO for 399,424 shares. Holowesko Partners Ltd. owns 1.24 million shares or 6.14% of their US portfolio. Moreover, America First Investment Advisors Llc has 3.68% invested in the company for 127,757 shares. The North Carolina-based Jolley Asset Management Llc has invested 2.78% in the stock. Alecta Pensionsforsakring Omsesidigt, a Sweden-based fund reported 4.24 million shares.
Ratings analysis reveals 0 of Mead Johnson Nutrition’s analysts are positive. Out of 4 Wall Street analysts rating Mead Johnson Nutrition, 0 give it “Buy”, 1 “Sell” rating, while 3 recommend “Hold”. The lowest target is $78.0 while the high is $90.0. The stock’s average target of $84 is -5.99% below today’s ($89.35) share price. MJN was included in 4 notes of analysts from October 28, 2016. Deutsche Bank maintained the shares of MJN in report on Friday, October 28 with “Hold” rating. As per Friday, October 28, the company rating was downgraded by JP Morgan. The firm has “Market Perform” rating by BMO Capital Markets given on Friday, February 10. The rating was initiated by Berenberg with “Sell” on Wednesday, January 18.
The stock increased 0.07% or $0.06 during the last trading session, reaching $89.35. About shares traded. Mead Johnson Nutrition CO (MJN) has risen 7.50% since May 31, 2016 and is uptrending. It has underperformed by 9.20% the S&P500.
Investors sentiment decreased to 0.99 in 2016 Q4. Its down 0.22, from 1.21 in 2016Q3. It is negative, as 8 investors sold Balchem Corporation shares while 71 reduced holdings. 21 funds opened positions while 57 raised stakes. 27.11 million shares or 1.34% more from 26.75 million shares in 2016Q3 were reported. State Of Alaska Department Of Revenue accumulated 0.03% or 3,440 shares. Stillwater Cap Advsrs Ltd Llc stated it has 13,076 shares or 0.29% of all its holdings. Swiss National Bank invested in 0.01% or 52,000 shares. Hudson Valley Invest Advsrs Adv accumulated 4,180 shares. Commonwealth Equity holds 0.01% of its portfolio in Balchem Corporation (NASDAQ:BCPC) for 8,797 shares. Rocky Mountain Advisers Ltd Liability Co has invested 0.01% in Balchem Corporation (NASDAQ:BCPC). Parametric Port Associate Limited Liability reported 0% of its portfolio in Balchem Corporation (NASDAQ:BCPC). Suntrust Banks Inc stated it has 0% of its portfolio in Balchem Corporation (NASDAQ:BCPC). Pnc Services Grp Inc owns 611,367 shares or 0.06% of their US portfolio. Guggenheim Capital Limited Liability Com holds 0.01% or 26,066 shares in its portfolio. Teachers Retirement Systems Of The State Of Kentucky owns 10,850 shares. Ameritas Invest Ptnrs has 0.01% invested in Balchem Corporation (NASDAQ:BCPC) for 2,718 shares. Pub Sector Pension Board invested in 0.02% or 22,567 shares. Sg Americas Limited Liability Corporation holds 0% of its portfolio in Balchem Corporation (NASDAQ:BCPC) for 2,559 shares. Ftb reported 836 shares or 0.01% of all its holdings.
Since December 7, 2016, it had 0 buys, and 4 selling transactions for $6.75 million activity. Backus William A. sold $4.05M worth of stock or 48,500 shares. ROSSI DINO A had sold 16,762 shares worth $1.42 million on Wednesday, December 7.
Among 2 analysts covering Balchem (NASDAQ:BCPC), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Balchem had 2 analyst reports since March 8, 2016 according to SRatingsIntel. The firm has “Sell” rating given on Friday, November 4 by Pivotal Research. The company was downgraded on Tuesday, March 8 by Sidoti.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.